A New Generation of Drug Therapies Requires New Business Strategies
Insight Exchange by L.E.K. Consulting · 2024-07-10 · 29 min
Episode notes
Today we look at how advanced therapeutic modalities (ATMs) are revolutionizing drug discovery, development and manufacturing, presenting both unparalleled opportunities and new challenges for businesses. Drawing from their knowledge, our experts Alex Vadas, Adam Siebert and Jeff Holder unpack how new drug therapies such as engineered cell therapies, gene therapies and nucleic acid therapies are revolutionizing patient care and treatment options. They highlight the need for innovative business strategies to navigate complex manufacturing processes and supply chain logistics, the role of regulatory engagement, and the influence of artificial intelligence (AI) and machine learning in the realm of drug discovery.
More from Insight Exchange by L.E.K. Consulting
All episodes →- Opportunities for Vehicle Electrification58 / 100
- How a Strategic Pricing Overhaul Boosted Growth at Education Perfect40 / 100
- Navigating the Shifting Landscape of Sports Fandom, Media Rights, and Fan Engagement76 / 100
- Elevating B2B Digital Commerce
- Investment Trends and Strategic Priorities in the Specialty Chemicals and Materials Industry